BD and Medtronic to develop new insulin pump infusion set

BD has announced a new partnership with Medtronic on the development of a new infusion set designed to improve insulin pump therapy.

The new insulin pump infusion set will incorporate with BD FlowSmart technology and is designed to work with both Medtronic insulin pumps and devices from most other manufacturers.

Insulin infusion sets deliver insulin from the pump to the body. This new system features a unique side-ported catheter designed to improve insulin flow, potentially reducing the number of flow interruptions.

Medtronic will commercialise the infusion set, while BD will manufacture the product. It has already been approved by US and Canadian regulators, with an application for European CE Mark approval having already been submitted.

Preclinical and clinical data generated by the device have demonstrated the benefits it can provide compared to other commonly used infusion sets.

Kenneth Miller, worldwide president for BD Medical's diabetes care business, said: "This technology is an extension of BD's longstanding commitment to deliver injection solutions, and builds on previous BD research that has advanced the science and understanding of insulin delivery as well as patient comfort."